What is the role of dexamethasone (corticosteroid) in treating bronchitis?

Dexamethasone for Bronchitis

Critical Distinction: Chronic Bronchitis vs. Bronchiolitis

Dexamethasone is NOT indicated for acute bronchiolitis in infants, but systemic corticosteroids (including dexamethasone) ARE strongly recommended for acute exacerbations of chronic bronchitis in adults.

The evidence base differs dramatically depending on which condition you're treating:

---

For Chronic Bronchitis (Adults with COPD)

Acute Exacerbations

A short course of systemic corticosteroids for 10-15 days should be given for acute exacerbations of chronic bronchitis, with substantial evidence supporting improved lung function and reduced treatment failure rates. 1, 2

• IV dexamethasone or other corticosteroids for hospitalized patients are proven effective 1, 3
• Oral corticosteroids (30-40 mg prednisone daily equivalent) for ambulatory patients are equally effective 3
• The recommended duration is 5-14 days, with evidence showing a 2-week course equivalent to 8 weeks, making shorter durations preferable to minimize side effects 2
• Corticosteroids improve FEV1, shorten recovery time, and reduce risk of early relapse and treatment failure 3
• This carries a Grade A recommendation with good level of evidence and substantial net benefit 1

Treatment algorithm for acute exacerbations: 4, 3

1. Start short-acting bronchodilators (β-agonists or anticholinergics) 4
2. Add systemic corticosteroids for 10-15 days 2, 3
3. Consider antibiotics if bacterial infection suspected (severe exacerbations, severe baseline airflow obstruction) 4

Stable Chronic Bronchitis

Long-term oral corticosteroids should NOT be used for stable chronic bronchitis—there is no evidence of benefit for cough or sputum production, and the risks of serious side effects are high. 1, 2

• This carries a Grade E/D recommendation (expert opinion with negative net benefit) 1
• Inhaled corticosteroids (not systemic) may be offered for patients with FEV1 <50% predicted or frequent exacerbations 1, 2
• Combined long-acting β-agonist plus inhaled corticosteroid reduces exacerbation rates and cough in long-term trials 2, 3

---

For Bronchiolitis (Infants)

Dexamethasone is NOT effective for acute bronchiolitis in infants and should not be used routinely.

• A large multicenter trial of 600 infants showed no significant difference in hospital admission rates (39.7% dexamethasone vs 41.0% placebo) or respiratory status after 4 hours 5
• Another randomized trial of 197 infants found no differences in duration of oxygen therapy or time to resolution of symptoms 6
• One small trial showed potential benefit in a highly selected subgroup (infants with eczema or family history of asthma), but this requires validation 7
• The evidence for bronchiolitis contradicts the strong evidence for chronic bronchitis exacerbations 5, 6

---

Important Caveats

Side effects of systemic corticosteroids include: 2, 3

• Hyperglycemia, weight gain, insomnia
• Increased infection risk
• With prolonged use: osteoporosis, immunosuppression, growth suppression in children

The benefits of short-term corticosteroids (10-15 days) in acute exacerbations of chronic bronchitis outweigh these risks, but long-term use is contraindicated. 3

Common pitfall: Confusing bronchiolitis (viral infection in infants) with chronic bronchitis (chronic inflammatory airway disease in adults, usually from smoking). The treatment paradigms are completely opposite. 5, 1

Most effective intervention for chronic bronchitis: Smoking cessation eliminates cough in 90% of patients—far more effective than any pharmacologic therapy. 4